Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative FOLFOX + Cetuximab +/- Bevacizumab for Liver Metastases
NCT00438737Phase 2Unknown
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jan 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in colorectal cancer (CRC), sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00438737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00438737.